ADC Therapeutics, an oncology drug discovery and development company headquartered in Biopôle (technological parc - Epalinges near Lausanne), today announced that it has raised $80 million through a private placement of equity. New investors include leading European and US-based investors alongside founding investor Auven Therapeutics and participation from AstraZeneca.

> Website